Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
207.94
+1.66 (0.80%)
Aug 7, 2026, 4:00 PM EDT - Market closed

Biogen Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,2853,0092,3751,0503,4192,261
Short-Term Investments
-807.2--1,4741,541
Cash & Short-Term Investments
1,2853,8162,3751,0504,8933,803
Cash Growth
-53.42%60.66%126.21%-78.54%28.67%45.68%
Accounts Receivable
1,8861,3421,4051,6641,7051,549
Other Receivables
512.8524.6464435.9431.4412.3
Total Trade Receivables
2,3981,8671,8692,1002,1361,962
Inventory
2,3842,1682,4612,5271,3441,352
Other Current Assets
1,2381,123752.51,1821,418740.8
Total Current Assets
7,3068,9747,4576,8599,7917,857
Net Property, Plant & Equipment
245.7265.4356.4420403.9375.4
Other Intangible Assets
13,5169,1799,6918,3631,8502,221
Goodwill
6,9916,4916,4796,2195,7495,761
Long-Term Investments
831.81,183560.57452,2352,832
Other Long-Term Assets
202.1292.5324.2928.61,2261,415
Total Assets
32,08729,44028,04926,84524,55423,877

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
403.9432424.2403.3491.5589.2
Accrued Expenses
2,6262,8032,8082,6242,5212,535
Current Portion of Long-Term Debt
800-1,749150-999.1
Other Current Liabilities
86.9114.8548.3257.4259.9174.7
Total Current Liabilities
3,9173,3495,5293,4343,2734,298
Long-Term Debt
7,2906,2874,5476,7886,2816,274
Long-Term Leases
264.8290.4334.5400333330.4
Other Long-Term Liabilities
1,7661,256922.81,4231,2792,015
Total Long-Term Liabilities
9,3227,8335,8058,6117,8938,619
Total Liabilities
13,23911,18311,33312,04511,16612,918

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.10.10.10.10.10.1
Treasury Stock
-2,977-2,977-2,977-2,977-2,977-2,977
Additional Paid-in Capital
983863.1569.4302.573.368.2
Accumulated Other Comprehensive Income
-127.7-182-136.2-153.7-164.9-106.7
Retained Earnings
20,97020,55319,26017,62816,46713,912
Total Common Shareholders' Equity
18,84818,25716,71614,79913,39810,896
Minority Interest
-----9.563.5
Shareholders' Equity
18,84818,25716,71614,79913,38810,960
Total Liabilities & Equity
32,08729,44028,04926,84524,55423,877

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
8,3556,5776,6307,3386,6147,604
Net Cash (Debt)
-7,070-2,762-4,255-6,288-1,721-3,801
Net Cash Growth
------
Net Cash Per Share
-47.86-18.77-29.17-43.19-11.79-25.41
Book Value
18,84818,25716,71614,79913,39810,896
Book Value Per Share
127.59124.11114.57101.6491.7772.84
Tangible Book Value
-1,6592,587545.9217.25,7992,914
Tangible Book Value Per Share
-11.2317.593.741.4939.7219.48
SEC Filings: 10-K · 10-Q